Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tracheobronchial amyloidosis.

S A Capizzi1, E Betancourt, U B Prakash

  • 1Division of Pulmonary and Critical Care Medicine and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|November 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Religion and HIV/AIDS stigma: implications for health professionals in Puerto Rico.

Global public health·2010
Same author

Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation.

Bone marrow transplantation·2001
Same author

Role of bronchoscopy in modern medical intensive care unit.

Clinics in chest medicine·2001
Same author

Varicella-zoster virus detection by polymerase chain reaction using bronchoalveolar lavage specimens.

American journal of respiratory and critical care medicine·2000
Same author

The role of anticholinergics in bronchoscopy. A randomized clinical trial.

Chest·2000
Same author

Alpha1-antitrypsin deficiency and inflammatory bowel diseases.

Mayo Clinic proceedings·2000
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Tracheobronchial amyloidosis presents with common airway symptoms and is rarely systemic. This condition often recurs, posing significant airway compromise challenges despite treatment.

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Rare Diseases

Background:

  • Tracheobronchial amyloidosis is a rare condition affecting the airways.
  • Understanding its presentation and clinical course is crucial for patient management.

Purpose of the Study:

  • To evaluate the clinical presentation and disease course of patients diagnosed with tracheobronchial amyloidosis.

Main Methods:

  • Retrospective review of medical records of patients with biopsy-proven tracheobronchial amyloidosis.
  • Analysis of clinical, historical, demographic, laboratory, and histological data.

Main Results:

  • 17 patients (mean age 56.6 years) diagnosed with tracheobronchial amyloidosis.
  • Common symptoms included dyspnea, cough, hemoptysis, and hoarseness.

Related Experiment Videos

  • Disease was typically localized to the tracheobronchial system, with rare association with systemic amyloidosis or multiple myeloma.

    • Conclusions:

    • Tracheobronchial amyloidosis symptoms mimic other airway disorders.
    • The condition is usually localized and not associated with systemic involvement.
    • Recurrence is common, and airway compromise remains a significant challenge despite interventions.